Abstracts

Potent Indoline CD4 Mimetics Enable Anti-Coreceptor Binding Site Antibodies to Mediate ADCC

Background: Antiretroviral therapy efficiently supresses HIV-1 replication but does not eradicate the virus. New approaches aimed at eliminating infected cells represent an appealing avenue to achieve this goal. Non-neutralizing antibodies (nnAbs) naturally present in the plasma of people living with HIV-1 (PLWH) have the potential to eliminate HIV-1-infected cells via antibody-dependent cellular cytotoxicity (ADCC). However,…

Treatment With AZD5582 + hetIL-15 Disrupts the Reservoir Establishment in SIV-Infected Macaques

Background: HIV infection cannot be cured despite suppressive antiretroviral therapy (ART) due to a persistent reservoir of latently-infected memory CD4 T cells harboring replication competent virus. Here, we tested the SMACm/cIAP antagonist AZD5582 in combination with the heterodimeric interleukin-15 (hetIL-15), the native form of the cytokine that activates and expands cytotoxic T and NK cells,…

Blockade of IFN-beta Reactivates HIV Reservoir in ART-Suppressed HIV-Infected BLT Humanized Mice

Background: Despite the efficient suppression of HIV-1 replication can be achieved with combined antiretroviral therapy (cART), viral latency and low levels of type I interferon (IFN-I) signaling persist during chronic infection. This sustained signaling may promote T cell exhaustion and foster viral persistence. Using cloned human neutralizing antibodies specifically against IFNα or IFNβ, here we…

A New CD4mc Enables Fc-Mediated Reservoir Reduction for Durable Post-ART HIV-1 Control in Hu-Mice

Background: Persistently-infected HIV-1-positive cells are heterogeneous, rare, and inherently difficult to eliminate; shock-and-kill approaches have thus far proven inefficient in measurably reducing infected cell frequencies in clinical trials. CD4-mimetic compounds (CD4mcs) sensitize HIV-1-infected cells to antibody-dependent cellular cytotoxicity (ADCC) mediated by CD4-induced (CD4i) non-neutralizing antibodies (nnAb) that are frequently found in plasma of people living…

Vectored Delivery of Closer-to-Germline Antibodies Can Mediate Long-Term SHIV Suppression

Background: Delivery of potent broadly neutralizing antibodies by recombinant adeno-associated virus (AAV) vectors can strongly and durably suppress ongoing viral replication after a single vector administration. We have successfully and durably suppressed viral replication in three SHIV-infected monkeys with this approach, including the ‘Miami monkey’ with well over 7 years of plasma viremia below 15…

Labelled High Affinity TCRs for Detection of HIV Epitopes on Infected Cells: How Low Can We Go?

Background: HIV proviruses persist in a non-productive state in CD4+ cells. There is no individual cell surface biomarker that uniquely identifies infected cells. However, some cells contain proviruses that are transcriptionally active and translationally competent, leading to expression of viral proteins and T cell epitopes. We used soluble affinity-enhanced T cell receptors (TCR) to investigate…

Identification and Targeting of Metabolic Profiles in CTL-Resistant, HIV-Infected CD4+ T-Cells

Background: HIV-specific CTL responses remain present even under long term ART, in association with residual HIV expression. Selection of CTL-resistant reservoir-harboring clones may contribute to HIV persistence, with BCL-2 overexpression being a previously reported mechanism. To identify additional mechanisms of resistance, we developed an in vitro model that compares infected cells surviving CTL pressure to…